Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Mar 16, 2026
Sale
Shares
2,902
Price
$41.20
Total Value
$119.57K
Shares Held After
35,195
% of Holdings
7.6%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Mar 16, 2026
Sale
Shares
2,921
Price
$40.11
Total Value
$117.16K
Shares Held After
38,097
% of Holdings
7.1%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Mar 16, 2026
Sale
Shares
395
Price
$41.30
Total Value
$16.31K
Shares Held After
18,863
% of Holdings
2.1%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Mar 16, 2026
Sale
Shares
600
Price
$41.30
Total Value
$24.78K
Shares Held After
236,984
% of Holdings
0.3%

Fortrea Holdings Inc. (FTRE)

Morais Mark A. — Chief Operating Officer
Mar 16, 2026
Sale
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
69,899
% of Holdings
2.5%
Mar 16, 2026
Sale
Shares
1,729
Price
$41.30
Total Value
$71.41K
Shares Held After
927,309
% of Holdings
0.2%
Mar 16, 2026
Sale
Shares
40,985
Price
$91.98
Total Value
$3.77M
Shares Held After
194,309
% of Holdings
17.4%

Mirum Pharmaceuticals, Inc. (MIRM)

Quan Joanne — CHIEF MEDICAL OFFICER
Mar 16, 2026
Sale
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
18,864
% of Holdings
27.9%

Mirum Pharmaceuticals, Inc. (MIRM)

Howe Jolanda — SVP, GLOBAL CONTROLLER
Mar 16, 2026
Sale
Shares
4,732
Price
$91.98
Total Value
$435.24K
Shares Held After
8,429
% of Holdings
36.0%
Mar 16, 2026
Sale
Shares
2,000
Price
$90.76
Total Value
$181.52K
Shares Held After
0
% of Holdings
100.0%

Mirum Pharmaceuticals, Inc. (MIRM)

Radovich Peter — PRESIDENT AND COO
Mar 16, 2026
Sale
Shares
16,515
Price
$91.98
Total Value
$1.52M
Shares Held After
40,272
% of Holdings
29.1%

Mirum Pharmaceuticals, Inc. (MIRM)

BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Mar 16, 2026
Sale
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
49,788
% of Holdings
12.8%

iRhythm Holdings, Inc. (IRTC)

Smith Mervin — EVP Strategic Business Ops
Mar 16, 2026
Sale
Shares
2,585
Price
$114.30
Total Value
$295.47K
Shares Held After
23,027
% of Holdings
10.1%

Guardant Health, Inc. (GH)

Bell Michael Brian — Chief Financial Officer
Mar 16, 2026
Sale
Shares
3,000
Price
$87.04
Total Value
$261.11K
Shares Held After
43,601
% of Holdings
6.4%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm & Corp Aff Officer
Mar 16, 2026
Sale
Shares
3,000
Price
$144.23
Total Value
$432.69K
Shares Held After
131,779
% of Holdings
2.2%
Mar 16, 2026
Sale
Shares
126
Price
$26.68
Total Value
$3.36K
Shares Held After
40,779
% of Holdings
0.3%
Mar 16, 2026
Sale
Shares
17,449
Price
$25.96
Total Value
$453.05K
Shares Held After
40,905
% of Holdings
29.9%

Upstream Bio, Inc. (UPB)

Ambrose Allison — General Counsel
Mar 16, 2026
Sale
Shares
475
Price
$9.29
Total Value
$4.41K
Shares Held After
16,525
% of Holdings
2.8%
Mar 16, 2026
Sale
Shares
2,093
Price
$9.29
Total Value
$19.44K
Shares Held After
72,907
% of Holdings
2.8%
Mar 16, 2026
Sale
Shares
2,770
Price
$47.30
Total Value
$131.03K
Shares Held After
288,976
% of Holdings
0.9%
Mar 16, 2026
Sale
Shares
11,813
Price
$46.57
Total Value
$550.08K
Shares Held After
291,746
% of Holdings
3.9%

GILEAD SCIENCES, INC. (GILD)

Dickinson Andrew D — Chief Financial Officer
Mar 16, 2026
Sale
Shares
3,000
Price
$144.23
Total Value
$432.69K
Shares Held After
179,191
% of Holdings
1.6%

Upstream Bio, Inc. (UPB)

Deykin Aaron — Chief Medical Officer
Mar 16, 2026
Sale
Shares
894
Price
$9.29
Total Value
$8.31K
Shares Held After
32,687
% of Holdings
2.7%

Upstream Bio, Inc. (UPB)

GRAY MICHAEL — CFO and COO
Mar 16, 2026
Sale
Shares
852
Price
$9.29
Total Value
$7.92K
Shares Held After
29,648
% of Holdings
2.8%

MYOMO, INC. (MYO)

Getz Heather C — Director
Mar 16, 2026
Purchase
Shares
20,000
Price
$0.70
Total Value
$13.97K
Shares Held After
131,754
% of Holdings
15.2%
Mar 16, 2026
Sale
Shares
10,349
Price
$48.26
Total Value
$499.44K
Shares Held After
245,834
% of Holdings
4.0%

CRISPR Therapeutics AG (CRSP)

Prasad Raju — Chief Financial Officer
Mar 16, 2026
Sale
Shares
4,021
Price
$48.26
Total Value
$194.05K
Shares Held After
13,773
% of Holdings
22.6%

CRISPR Therapeutics AG (CRSP)

Prasad Raju — Chief Financial Officer
Mar 16, 2026
Sale
Shares
5,848
Price
$48.26
Total Value
$282.22K
Shares Held After
17,794
% of Holdings
24.7%

CRISPR Therapeutics AG (CRSP)

KASINGER JAMES R. — General Counsel and Secretary
Mar 16, 2026
Sale
Shares
3,450
Price
$48.26
Total Value
$166.50K
Shares Held After
91,240
% of Holdings
3.6%

CRISPR Therapeutics AG (CRSP)

Patel Naimish — Chief Medical Officer
Mar 16, 2026
Sale
Shares
3,150
Price
$48.26
Total Value
$152.02K
Shares Held After
13,143
% of Holdings
19.3%
Mar 16, 2026
Sale
Shares
4,500
Price
$19.66
Total Value
$88.46K
Shares Held After
200,641
% of Holdings
2.2%
Mar 16, 2026
Sale
Shares
8,000
Price
$19.66
Total Value
$157.26K
Shares Held After
205,141
% of Holdings
3.8%
Mar 16, 2026
Sale
Shares
160
Price
$537.37
Total Value
$85.98K
Shares Held After
40,513
% of Holdings
0.4%
Mar 16, 2026
Sale
Shares
763
Price
$536.49
Total Value
$409.34K
Shares Held After
40,673
% of Holdings
1.8%
Mar 16, 2026
Sale
Shares
1,551
Price
$535.59
Total Value
$830.70K
Shares Held After
41,436
% of Holdings
3.6%
Mar 16, 2026
Sale
Shares
1,779
Price
$534.47
Total Value
$950.82K
Shares Held After
42,987
% of Holdings
4.0%
Mar 16, 2026
Sale
Shares
2,526
Price
$533.65
Total Value
$1.35M
Shares Held After
44,766
% of Holdings
5.3%
Mar 16, 2026
Sale
Shares
1,597
Price
$532.66
Total Value
$850.66K
Shares Held After
47,292
% of Holdings
3.3%
Mar 16, 2026
Sale
Shares
564
Price
$531.69
Total Value
$299.87K
Shares Held After
48,889
% of Holdings
1.1%
Mar 16, 2026
Sale
Shares
200
Price
$530.73
Total Value
$106.15K
Shares Held After
49,453
% of Holdings
0.4%
Mar 16, 2026
Sale
Shares
360
Price
$529.16
Total Value
$190.50K
Shares Held After
49,653
% of Holdings
0.7%
Mar 16, 2026
Sale
Shares
30,000
Price
$17.48
Total Value
$524.43K
Shares Held After
1,095,562
% of Holdings
2.7%

Upstream Bio, Inc. (UPB)

Houghton Adam — Chief Business Officer
Mar 16, 2026
Sale
Shares
699
Price
$9.29
Total Value
$6.49K
Shares Held After
24,301
% of Holdings
2.8%

CG Oncology, Inc. (CGON)

Mulay James — Director
Mar 16, 2026
Sale
Shares
1,310
Price
$63.50
Total Value
$83.19K
Shares Held After
0
% of Holdings
100.0%

CG Oncology, Inc. (CGON)

Mulay James — Director
Mar 16, 2026
Sale
Shares
654
Price
$63.50
Total Value
$41.53K
Shares Held After
0
% of Holdings
100.0%

ORTHOPEDIATRICS CORP (KIDS)

Hauser Joseph W — Pres. Trauma & Def. Correction
Mar 16, 2026
Sale
Shares
8,596
Price
$17.25
Total Value
$148.28K
Shares Held After
194,767
% of Holdings
4.2%

ORTHOPEDIATRICS CORP (KIDS)

Hite Fred — Director
Mar 16, 2026
Sale
Shares
12,993
Price
$17.25
Total Value
$224.13K
Shares Held After
277,477
% of Holdings
4.5%
Mar 16, 2026
Sale
Shares
19,535
Price
$17.25
Total Value
$336.98K
Shares Held After
298,020
% of Holdings
6.2%

ORTHOPEDIATRICS CORP (KIDS)

Odle Gregory A — President of Scoliosis
Mar 16, 2026
Sale
Shares
8,433
Price
$17.25
Total Value
$145.47K
Shares Held After
187,735
% of Holdings
4.3%

ORTHOPEDIATRICS CORP (KIDS)

Gerritzen Daniel J — General Counsel and Secretary
Mar 16, 2026
Sale
Shares
8,614
Price
$17.25
Total Value
$148.59K
Shares Held After
149,533
% of Holdings
5.4%
Version: v26.3.33